September 22, 2026

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 50.89% Upside in the Biotech Sector

ImmunityBio, Inc. (NASDAQ: IBRX), a prominent player in the biotechnology sector, is currently capturing investor attention with its significant growth potential. With a market capitalization of..

PACS Group, Inc. (PACS) Stock Analysis: Exploring a 40% Potential Upside in Healthcare Facilities

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of individual investors with..

LivaNova PLC (LIVN) Stock Analysis: A Healthcare Innovator with a 13.98% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a leading player in the healthcare sector’s medical devices industry, offers investors a compelling growth story underpinned by its innovative product offerings..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a key player in the medical devices sector, is making waves with its innovative solutions for diabetes management. Headquartered in..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Significant Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a pioneering biopharmaceutical company, presents a compelling opportunity for investors looking to capitalize on the healthcare sector’s potential, particularly within..

Vera Therapeutics, Inc. (VERA) Stock Analysis: A Biotechnology Player with 126% Upside Potential

For investors with an eye on the biotechnology sector, Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing opportunity. The company, with a market capitalization of $2.47..

Harmony Biosciences Holdings (HRMY): Stock Analysis Reveals 12.5% Potential Upside in Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its innovative approach to treating rare neurological diseases. Based in Plymouth Meeting,..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: A Closer Look at Its 21.5% Revenue Growth and Market Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the forefront of the healthcare sector with its innovative approach to diagnostics and research. The Seattle-based company, which was..

CONMED Corporation (CNMD) Stock Analysis: Potential Upside and Analyst Ratings Highlight Investment Considerations

Investors eyeing opportunities in the healthcare sector should take a closer look at CONMED Corporation (CNMD), a medical technology company with a robust portfolio of innovative..

Ligand Pharmaceuticals (LGND): Analyst Consensus and Growth Potential in the Biotech Arena

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a notable player in the biotechnology sector, with a market capitalization of $5.78 billion. This U.S.-based biopharmaceutical company has..

Clover Health Investments, Corp (CLOV): Exploring the 18.39% Potential Upside and Analyst Ratings

Clover Health Investments, Corp (NASDAQ: CLOV) is capturing investor attention with its promising growth prospects in the healthcare sector. With a market capitalization of $2.41 billion,..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 35% Potential Upside and Robust Growth Prospects

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Schrodinger, Inc. (SDGR) Stock Analysis: Navigating Highs with a 52-Week Peak Amidst Analyst Skepticism

Schrodinger, Inc. (NASDAQ: SDGR), a prominent player in the health information services sector, is making waves in the market with its recent price performance, hitting the..

Edgewise Therapeutics, Inc. (EWTX)

⚠️ No article content returned.

..

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Unpacking a 59.91% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is a compelling prospect in the biotechnology sector, boasting a market capitalization of $9.69 billion. As a key player in the..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 106% Upside in the Biotechnology Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) has captured investor attention with a potential upside of 106.47%, according to recent analyst ratings. As a player in the biotechnology..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Powerhouse with a 26% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is making waves in the biotechnology sector, particularly in the field of eye care therapeutics. With a market capitalization of $3.62..

Kiniksa Pharmaceuticals Interna (KNSA) Stock Analysis: Unlocking a 25% Upside Potential with Strong Buy Ratings

Kiniksa Pharmaceuticals Interna (NASDAQ: KNSA) is catching the eye of investors with its robust growth trajectory and promising market position in the healthcare sector. This UK-based..

Immunovant, Inc. (IMVT) Stock Analysis: Potential Upside and Strong Buy Ratings Make This Biotech a Compelling Investment

Investors looking to capitalize on the potential within the biotech sector might find Immunovant, Inc. (NASDAQ: IMVT) a particularly intriguing opportunity. With a market capitalization of..

Travere Therapeutics, Inc. (TVTX): Investor Outlook and 18% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands out in the biotechnology sector with a focus on developing therapies for rare kidney and metabolic diseases. The San Diego-based..

Search

Funds

September 22, 2026

Search

Funds

September 22, 2026

FTSE 100

Funds